Search results
Showing 736 to 750 of 2042 results for guidelines
Tailored content for our communities: Medicines and prescribing, general practice, social care, the public, library and knowledge services and local government.
Evidence summaries: new medicines – Integrated process statement (PMG11)
Evidence summaries: new medicines – Integrated process statement
Evidence-based recommendations on bulevirtide (Hepcludex) for chronic hepatitis D in adults.
self-assessment tools. The resource brings together our quality standards and guidelines on managing medicines in an easy to use format,...
Summary of the evidence on antimicrobial prescribing: delafloxacin
Management of vomiting in children and young people with gastroenteritis: ondansetron (ESUOM34)
Summary of the evidence on ondansetron for the management of vomiting in children and young people with acute gastroenteritis...
Evidence-based recommendations on rituximab (MabThera) with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in adults.
A quick and easy-to-read guide to the standard of care you should expect from a home care provider.
A quick guide to enabling positive lives for autistic adults for social workers.
Alair bronchial thermoplasty system for adults with severe difficult to control asthma (MIB71)
NICE has developed a medtech innovation briefing (MIB) on the Alair bronchial thermoplasty system for adults with severe, difficult to control asthma
NICE has developed a medtech innovation briefing (MIB) on IQoro for stroke-related dysphagia .
NICE no longer plans to develop guidance on Freelite assays for diagnosing multiple myeloma and related conditions in primary care. We will review this decision if a stakeholder notifies NICE again of the topic
Show all sections
Sections for DG47
Etanercept and efalizumab for the treatment of adults with psoriasis (TA103)
Evidence-based recommendations on etanercept (Enbrel) for treating severe psoriasis in adults.
Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)
NICE has developed a medtech innovation briefing (MIB) on the Alere Afinion CRP for C-reactive protein testing in primary care
NICE'S quick guide to developing a positive working culture for supporting disabled children and young people with severe complex needs